Roselabs Finance (Small Cap - Next Multibagger) Share Target 2024, 2025 To 2039
|
Roselabs Finance Limited |
|||
|
Price: ₹33.62 | ||
| 52 Week Low: ₹19.11 52 Week High: ₹41.51 |
|||
| Market Capital: 32.21 Crore (Smallcap) | |||
| -> | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Roselabs Finance Share Price Target For 2024
- 1.1.1: Roselabs Finance Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: Roselabs Finance Share Price Target For 2025
- 1.2.1: Roselabs Finance Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Roselabs Finance Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: Roselabs Finance Financial Performance
- 3.0.1: Is Roselabs Finance A Good Buy For Long Term?
To predict the Roselabs Finance's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Roselabs Finance Share Price Target For 2024
The line chart displays the monthly closing prices of Roselabs Finance with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Roselabs Finance shares in 2024, see the table below.
Roselabs Finance Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 35.53 (+5.68%) | Price Action: 18 Oct 2024 Low |
| 2024 Target 2 | 35.15 (+4.55%) | Price Action: 21 Oct 2024 Low |
| 2024 Target 1 | 34.8 (+3.5%) | Price Action: 09 Feb 2024 Low |
| Current Price | 33.62 | Roselabs Finance's share price as of 26 Dec 2024 |
| Stop Loss 1 | 33.1 (-1.55%) | Price Action: Oct 2014 Low |
| Stop Loss 2 | 32.69 (-2.77%) | Price Action: 24 Jan 2024 High |
| Stop Loss 3 | 32.35 (-3.78%) | Price Action: 10 Jul 2024 High |
Short-Term Technical Outlook
Current Technical Position: Roselabs Finance is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 50-day moving average at ₹35.6 serves as the nearest technical reference point.
Historical Returns: 3-month: +14.35% | 6-month: +2.56% | 1-year: +56.52%
Roselabs Finance Share Price Target For 2025
The line chart displays the monthly closing prices of Roselabs Finance with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Roselabs Finance shares in 2025, see the table below.
Roselabs Finance Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 49.56 (+47.41%) | Price Action: Chart |
| 2025 Target 2 | 48.64 (+44.67%) | Price Action: Chart |
| 2025 Target 1 | 48.16 (+43.24%) | Fibonacci Extension Level 64.90% |
| Current Price | 33.62 | Roselabs Finance's share price as of 26 Dec 2024 |
| Stop Loss 1 | 30.27 (-9.97%) | Price Action: 07 Aug 2024 High |
| Stop Loss 2 | 29.95 (-10.92%) | Price Action: 08 Apr 2024 High |
| Stop Loss 3 | 29.63 (-11.87%) | Price Action: 18 Jan 2024 High |
Long-Term Technical Outlook
52-Week Range Analysis: Roselabs Finance is currently trading at 64.8% of its 52-week range (₹19.11 - ₹41.51).
Long-Term Trend Analysis: The stock is maintaining a bullish long-term trend, trading above both 150-day and 250-day moving averages.
Long-Term Performance: 1-year: +56.52% | 3-year: +29.81% | 5-year: +140.66%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Roselabs Finance Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹33.62 | ||
| 2024 | ₹34.50 | +2.61% | ₹35.50 |
| 2025 | ₹37.09 | +7.5% | ₹37.65 |
| 2026 | ₹35.88 | -3.26% | ₹39.22 |
| 2027 | ₹37.40 | +4.23% | ₹42.74 |
| 2028 | ₹39.97 | +6.87% | ₹46.26 |
| 2029 | ₹47.93 | +19.91% | ₹49.78 |
| 2030 | ₹50.48 | +5.32% | ₹51.24 |
| 2031 | ₹47.96 | -4.99% | ₹53.30 |
| 2032 | ₹49.20 | +2.58% | ₹56.82 |
| 2033 | ₹51.84 | +5.36% | ₹60.33 |
| 2034 | ₹61.35 | +18.34% | ₹63.85 |
| 2035 | ₹63.88 | +4.12% | ₹64.84 |
| 2036 | ₹60.04 | -6.01% | ₹67.37 |
| 2037 | ₹61.00 | +1.59% | ₹70.89 |
| 2038 | ₹63.70 | +4.42% | ₹74.41 |
| 2039 | ₹77.21 | +21.2% | ₹78.37 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Roselabs Finance Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 32.21 Crore | Market valuation of Roselabs Finance's shares. |
| Revenue (TTM) | 1.13 Crore | Total revenue generated by Roselabs Finance over the past twelve months. |
| Net Income (TTM) | -13.2 Lakh | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | -15.25% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +0.98% | Net income as a percentage of revenue, after all expenses. |
Is Roselabs Finance A Good Buy For Long Term?
Roselabs Finance, a small-cap stock with a market capitalization of 32.21 Crore, has shown mixed financial performance in the last 12 months. Despite generating revenue of 1.13 Crore, the company incurred a net loss of -13.2 Lakh, resulting in a low-profit margin of 0.98%. While the company has delivered positive returns over the past 12 months (44.11%) and 5 years (101.31%), its recent performance has been volatile, with a sharp decline in the past 3 months (-18.54%). Given the company's small size, recent losses, and volatile returns, it may be considered a moderate buy for long-term investors with a high-risk tolerance and a long-term investment horizon. Potential investors should carefully evaluate the company's financial health and market conditions before making any investment decisions.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
